Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-31), Azelis Group NV's Beta is 0.4783.
Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.
Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)
Azelis Group NV Beta Related Terms
Azelis Group NV Beta Historical Data
* Premium members only.
The historical data trend for Azelis Group NV's Beta can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, Azelis Group NV's Beta, along with its competitors' market caps and Beta data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Azelis Group NV Beta vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Azelis Group NV's Beta distribution charts can be found below:
* The bar in red indicates where Azelis Group NV's Beta falls into.
Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.
Azelis Group NV (AZLGF) has a Beta of 0.4783 as of Jul. 31, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Azelis Group NV and its competitors.
Is Azelis Group NV's Beta too high?
Azelis Group NV's current Beta is 0.4783. Overall, Azelis Group NV has a GF Score™ of 74/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Azelis Group NV's Beta compare to LIN and SHW?
Azelis Group NV's Beta of 0.4783 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Chemicals company?
A good Beta depends on the Chemicals industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Azelis Group NV and its competitors. Azelis Group NV's current Beta is 0.4783. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Azelis Group NV stock overvalued right now?
Based on GuruFocus' analysis, Azelis Group NV (AZLGF) is currently considered Significantly Undervalued. The stock's GF Value™ is $18.43, compared to a current price of $11.32 — trading 38.6% below its estimated fair value. The current Beta is 0.4783. Azelis Group NV's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Azelis Group NV (AZLGF), the current Beta is 0.4783 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Azelis Group NV (AZLGF) Overvalued in 2026?
Based on GuruFocus' analysis, Azelis Group NV stock appears to be undervalued.
The current stock price of $11.32 is trading 38.6% below its estimated GF Value™ of $18.43.
GuruFocus considers Azelis Group NV to be Significantly Undervalued.
Key valuation signals for AZLGF:
Beta: 0.4783
GF Value™: $18.43 vs. price of $11.32 (38.6% below fair value)
No single metric tells the full story. See the AZLGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Azelis Group NV is an innovation service provider and distributor of speciality chemicals and food ingredients. The Group provides innovation services, multi-product formulations, technical and regulatory expertise, co-creation support, digital solutions, and supply chain services. It serves Food & Nutrition, Animal Nutrition, Personal Care, Home Care & Industrial Cleaning, Pharmaceuticals & Healthcare, Agriculture & Environmental Solutions, Flavours & Fragrances, and Nutraceuticals. The Group operates through four segments: EMEA, Americas, Asia Pacific, and Group holding & other, covering operating companies across Europe, the Middle East and Africa, the United States, Canada, Mexico and South America, Asia, and the Pacific region.
74GF Score
Get the complete analysis for AZLGF
Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AZLGF has been successfully added to your 
